Show source-provided references
2. Goudarzi, M., Seyedjavadi, S.S., Goudarzi, H., Mehdizadeh Aghdam, E., and Nazeri, S. (2014). Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica, 2014.
10.1155/2014/916826 ↗5. Meeting the societal need for new antibiotics: The challenges for the pharmaceutical industry
10.1111/bcp.12401 ↗7. Centers for Disease Control and Prevention (2018, August 22). QuickStats: Rates of Clostridium Difficile Infection among Hospitalized Patients Aged ≥65 Years,* by Age Group—National Hospital Discharge Survey, United States, 1996–2009, Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a7.htm.
10. For the Polymer Alternative for CDI Treatment (PACT) Investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: Results from two multinational, randomized, controlled trials
10.1093/cid/ciu313 ↗17. Bender, K.O., Garland, M., Ferreyra, J.A., Hryckowian, A.J., Child, M.A., Puri, A.W., Solow-Cordero, D.E., Higginbottom, S.K., Segal, E., and Banaei, N. (2015). A small-molecule antivirulence agent for treating Clostridium difficile infection. Sci. Transl. Med., 7.
10.1126/scitranslmed.aac9103 ↗18. Lacy, D.B. (2018, August 22). Pre-Clinical Evaluation of Clostridium Difficile Toxin Inhibitors. Available online: http://grantome.com/grant/NIH/I01-BX002943-01.
19. Larabee, J.L., Bland, S.J., Hunt, J.J., and Ballard, J.D. (2017). Intrinsic toxin-derived peptides destabilize and inactivate Clostridium difficile TcdB. MBio, 8.
10.1128/mBio.00503-17 ↗20. Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)
10.1016/j.bmcl.2018.01.005 ↗26. Chaumont, F. (2018, August 22). Manual Counting: Documentation. Available online: www.icy.bioimageanalysis.org/plugin/Manual_Counting.
28. Brocher, J., and Wagner, T. (2018, August 22). BioVoxxel Toolbox (ImageJ/Fiji). Available online: www.biovoxxel.de.
32. Hastie, T., Tibshirani, R., and Friedman, J.H. (2009). The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Springer. [2nd ed.].
10.1007/978-0-387-84858-7 ↗33. Japkowicz, N., and Shah, M. (2011). Evaluating Learning Algorithms: A Classification Perspective, Cambridge University Press.
10.1017/CBO9780511921803 ↗34. Bishop, C.M. (2006). Pattern Recognition and Machine Learning, Springer.
35. Devroye, L., Gyorfi, L., and Lugosi, G. (1996). A Probabilistic Theory of Pattern Recognition, Springer.
10.1007/978-1-4612-0711-5 ↗36. Duda, R.O., Hart, P.E., and Stork, D.G. (2000). Pattern Classification, Wiley. [2nd ed.].
37. Mitchell, T. (1997). Machine Learning, McGraw Hill.
40. John, G.H., and Langley, P. (1995, January 18–20). Estimating continuous distributions in bayesian classifiers. Proceedings of the 11th Conference on Uncertainty in Artificial Intelligence, Montreal, QC, Canada.
44. Vangelis, M., Ion, A., and Geogios, P. Spam Filtering with Naïve Bayes—Which Naïve Bayes? In Proceedings of the 3rd Conference on Email and Anti-Spam, Mountain View, CA, USA, 27–28 July 2006.
47. A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size
10.1177/0962280215602040 ↗51. Cortes, C., and Mohri, M. (2004). AUC optimization vs. error rate minimization. Advances in Neural Information Processing Systems, MIT Press.